Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1971 Dec;9(6):785–793.

Synthesis and secretion of IgE by an established human myeloma cell line

K Nilsson
PMCID: PMC1713130  PMID: 5158272

Abstract

The rate of IgE production in vitro and the cell population proliferation rate by the established human myeloma line 266 Bl have been studied quantitatively under various tissue culture conditions. The rate of extracellular IgE accumulation depended on the type of medium used, the cell density and the period of time elapsed after explantation. The maximum production rate of 8·1 × 10−12 g IgE/cell/48 hr was noticed at cell densities <106/30 ml and with the presence of feeder human skin fibroblasts or glia-like cells or with the use of conditioned media harvested from such cells. The rate of cell proliferation and secretion of IgE to the medium ran parallel suggesting that the IgE production is highest when cells are in the best physiological condition. During more than one year the rate of synthesis of IgE remained stable. This functionally stable human myeloma line is suitable for further studies on immunoglobulin biosynthesis at the cellular and subcellular level under the tissue culture conditions found optimal in this study.

Full text

PDF
785

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaumont J. L., Jacotot B., Vilain C., Beaumont V. Présence d'un auto-anticorps anti-beta-lipoprotéine dans un sérum de myélome. C R Acad Sci Hebd Seances Acad Sci D. 1965 May 31;260(22):5960–5962. [PubMed] [Google Scholar]
  2. Buell D. N., Fahey J. L. Limited periods of gene expression in immunoglobulin-synthesizing cells. Science. 1969 Jun 27;164(3887):1524–1525. doi: 10.1126/science.164.3887.1524. [DOI] [PubMed] [Google Scholar]
  3. Byars N., Kidson C. Programmed synthesis and export of immunoglobulin by synchronized myeloma cells. Nature. 1970 May 16;226(5246):648–650. doi: 10.1038/226648a0. [DOI] [PubMed] [Google Scholar]
  4. Johansson S. G., Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology. 1967 Oct;13(4):381–394. [PMC free article] [PubMed] [Google Scholar]
  5. Johansson S. G., Bennich H., Wide L. A new class of immunoglobulin in human serum. Immunology. 1968 Feb;14(2):265–272. [PMC free article] [PubMed] [Google Scholar]
  6. Matsuoka Y., Moore G. E., Yagi Y., Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1246–1250. doi: 10.3181/00379727-125-32327. [DOI] [PubMed] [Google Scholar]
  7. Matsuoka Y., Takahashi M., Yagi Y., Moore G. E., Pressman D. Synthesis and secretion of immunoglobulins by established cell lines of human hematopoietic origin. J Immunol. 1968 Dec;101(6):1111–1120. [PubMed] [Google Scholar]
  8. Matsuoka Y., Yagi Y., Moore G. E., Pressman D. Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium. J Immunol. 1969 May;102(5):1136–1143. [PubMed] [Google Scholar]
  9. Nilsson K., Bennich H., Johansson S. G., Pontén J. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Clin Exp Immunol. 1970 Oct;7(4):477–489. [PMC free article] [PubMed] [Google Scholar]
  10. Nilsson K. Characteristics of established myeloma and lymphoblastoid cell lines derived from an E myeloma patient: a comparative study. Int J Cancer. 1971 May 15;7(3):380–396. doi: 10.1002/ijc.2910070303. [DOI] [PubMed] [Google Scholar]
  11. Pontén J., Macintyre E. H. Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand. 1968;74(4):465–486. doi: 10.1111/j.1699-0463.1968.tb03502.x. [DOI] [PubMed] [Google Scholar]
  12. Salmon S. E., McIntyre O. R., Ogawa M. IgE myeloma: total body tumor cell number and synthesis of IgE and DNA. Blood. 1971 Jun;37(6):696–705. [PubMed] [Google Scholar]
  13. Terry W. D., Boyd M. M., Rea J. S., Stein R. Human M-proteins with antibody activity for nitrophenyl ligands. J Immunol. 1970 Jan;104(1):256–259. [PubMed] [Google Scholar]
  14. WALDENSTROEM J., WINBLAD S., HAELLEN J., LIUNGMAN S. THE OCCURRENCE OF SEROLOGICAL "ANTIBODY" REAGINS OR SIMILAR GAMMA-GLOBULINS IN CONDITIONS WITH MONOCLONAL HYPERGAMMAGLOBULINEMIA, SUCH AS MYELOMA, MACROGLOBULINEMIA ETC. Acta Med Scand. 1964 Nov;176:619–631. doi: 10.1111/j.0954-6820.1964.tb00666.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES